Q3 2025 · 13F-HR
M28 Capital Management LPholdings as filed
Filed 2025-11-13 · accession 0000902664-25-004910
$68.0M
Reported value
9
Positions
2025-09-30
Period end
The Brief · M28 Capital Management LP · Q3 2025
AI · grounded in 13F
M28 Capital Management LP established a new position in WVE valued at $41.46M. The fund also initiated new stakes in IVVD for $10.17M and TGTX for $5.84M. Additional new positions include GUTS, ARWR, and PRQR.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| Y95308105 | WVE | WAVE LIFE SCIENCES LTD | $41.5M | 61.0% | 5,664,548 | Common | SOLE |
| 00534A102 | IVVD | INVIVYD INC | $10.2M | 15.0% | 9,248,250 | Common | SOLE |
| 88322Q108 | TGTX | TG THERAPEUTICS INC | $5.8M | 8.58% | 161,600 | Common | SOLE |
| 35168W103 | GUTS | FRACTYL HEALTH INC | $3.0M | 4.34% | 1,856,117 | Common | SOLE |
| 04280A100 | ARWR | ARROWHEAD PHARMACEUTICALS IN | $2.3M | 3.42% | 67,400 | Common | SOLE |
| N71542109 | PRQR | PROQR THRAPEUTICS N V | $2.2M | 3.19% | 1,019,498 | Common | SOLE |
| 77313F106 | RCKT | ROCKET PHARMACEUTICALS INC | $1.3M | 1.85% | 385,680 | Common | SOLE |
| 82686Q101 | SLN | SILENCE THERAPEUTICS PLC | $960,669 | 1.41% | 185,100 | Common | SOLE |
| 231269309 | CRIS | CURIS INC | $864,958 | 1.27% | 521,059 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.